Crinetics Pharmaceuticals gains amid pitch at Sohn charity conference

seekingalpha04-03

Crinetics Pharmaceuticals (NASDAQ:CRNX) rose 1.2% amid a bullish pitch at the Sohn Investment conference in New York City. Crinetics (CRNX) was presented at Next Wave Sohn by Stempoint Capital's ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2424823133?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1266320932/image_1266320932.jpg","is_english":true,"pubTime":"2024-04-03 23:37","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2424823133","market":"us","top_or_hot":-1,"title":"Crinetics Pharmaceuticals gains amid pitch at Sohn charity conference","media":"seekingalpha","content":"<div>\n<p>Crinetics Pharmaceuticals (NASDAQ:CRNX) rose 1.2% amid a bullish pitch at the Sohn Investment conference in New York City.\nCrinetics (CRNX) was presented at Next Wave Sohn by Stempoint Capital's ...</p>\n\n<a href=\"https://seekingalpha.com/news/4086897-crinetics-pharmaceuticals-gains-amid-pitch-at-sohn-charity-conference\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Crinetics Pharmaceuticals gains amid pitch at Sohn charity conference</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCrinetics Pharmaceuticals gains amid pitch at Sohn charity conference\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-03 23:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4086897-crinetics-pharmaceuticals-gains-amid-pitch-at-sohn-charity-conference><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Crinetics Pharmaceuticals (NASDAQ:CRNX) rose 1.2% amid a bullish pitch at the Sohn Investment conference in New York City.\nCrinetics (CRNX) was presented at Next Wave Sohn by Stempoint Capital's ...</p>\n\n<a href=\"https://seekingalpha.com/news/4086897-crinetics-pharmaceuticals-gains-amid-pitch-at-sohn-charity-conference\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CRNX","symbol_name":"Crinetics Pharmaceuticals Inc.","start_time":0,"source_url":"https://seekingalpha.com/news/4086897-crinetics-pharmaceuticals-gains-amid-pitch-at-sohn-charity-conference","article_id":"2424823133","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1266320932/image_1266320932.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2424823133","pubTimestamp":1712158629,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Crinetics Pharmaceuticals rose 1.2%amid a bullish pitch at the Sohn Investment conference in New York City.Crinetics  was presented at Next Wave Sohn by Stempoint Capital's Michelle Ross, according to traders attending the event .Ross has a price target of $339 for Crinetics.More on Crinetics Pharmaceuticals  Crinetics: Paltusotine's Phase 3 Triumph Transforms Trajectory  Crinetics Pharmaceuticals, Inc.  Q4 2023 Earnings Call Transcript Crinetics gains as late-stage trial for lead drug succeeds Crinetics reports encouraging Phase 2 data for carcinoid syndrome drug Seeking Alpha’s Quant Rating on Crinetics Pharmaceuticals","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"CRNX":"Crinetics Pharmaceuticals Inc.","BK4139":"生物科技"},"translate_title":"Crinetics Pharmaceuticals在Sohn慈善会议上获得收益","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRNX":1},"content_text":"Crinetics Pharmaceuticals (NASDAQ:CRNX) rose 1.2% amid a bullish pitch at the Sohn Investment conference in New York City.\nCrinetics (CRNX) was presented at Next Wave Sohn by Stempoint Capital's Michelle Ross, according to traders attending the event .\nRoss has a price target of $339 for Crinetics.\n\n\nMore on Crinetics Pharmaceuticals  Crinetics: Paltusotine's Phase 3 Triumph Transforms Trajectory (Rating Upgrade) Crinetics Pharmaceuticals, Inc. (CRNX) Q4 2023 Earnings Call Transcript Crinetics gains as late-stage trial for lead drug succeeds Crinetics reports encouraging Phase 2 data for carcinoid syndrome drug Seeking Alpha’s Quant Rating on Crinetics Pharmaceuticals","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.5","shortVersion":"4.22.5","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2424823133"}